197 related articles for article (PubMed ID: 22074426)
1. Prodrugs in photodynamic anticancer therapy.
Musiol R; Serda M; Polanski J
Curr Pharm Des; 2011; 17(32):3548-59. PubMed ID: 22074426
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates as potential photodynamic therapeutical agents.
Zhu CF; Battah S; Kong X; Reeder BJ; Hider RC; Zhou T
Bioorg Med Chem Lett; 2015 Feb; 25(3):558-61. PubMed ID: 25556100
[TBL] [Abstract][Full Text] [Related]
3. Activity of phosphatase-sensitive 5-aminolevulinic acid prodrugs in cancer cell lines.
Herceg V; Lange N; Allémann E; Babič A
J Photochem Photobiol B; 2017 Jun; 171():34-42. PubMed ID: 28472723
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy: an update.
Dima VF; Vasiliu V; Dima SV
Roum Arch Microbiol Immunol; 1998; 57(3-4):207-30. PubMed ID: 11845434
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy.
Zhu W; Gao YH; Song CH; Lu ZB; Namulinda T; Han YP; Yan YJ; Wang LX; Chen ZL
Photochem Photobiol Sci; 2017 Nov; 16(11):1623-1630. PubMed ID: 28933502
[TBL] [Abstract][Full Text] [Related]
7. Improved peptide prodrugs of 5-ALA for PDT: rationalization of cellular accumulation and protoporphyrin IX production by direct determination of cellular prodrug uptake and prodrug metabolization.
Giuntini F; Bourré L; MacRobert AJ; Wilson M; Eggleston IM
J Med Chem; 2009 Jul; 52(13):4026-37. PubMed ID: 19492812
[TBL] [Abstract][Full Text] [Related]
8. Dual pH-responsive 5-aminolevulinic acid pseudopolyrotaxane prodrug micelles for enhanced photodynamic therapy.
Tong H; Wang Y; Li H; Jin Q; Ji J
Chem Commun (Camb); 2016 Mar; 52(20):3966-9. PubMed ID: 26882232
[TBL] [Abstract][Full Text] [Related]
9. Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments.
Garland MJ; Cassidy CM; Woolfson D; Donnelly RF
Future Med Chem; 2009 Jul; 1(4):667-91. PubMed ID: 21426032
[TBL] [Abstract][Full Text] [Related]
10. Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement.
Yang X; Palasuberniam P; Kraus D; Chen B
Int J Mol Sci; 2015 Oct; 16(10):25865-80. PubMed ID: 26516850
[TBL] [Abstract][Full Text] [Related]
11. α-Bisabolol improves 5-aminolevulinic acid retention in buccal tissues: Potential application in the photodynamic therapy of oral cancer.
Quintanilha NP; Dos Santos Miranda Costa I; Freiman de Souza Ramos M; Campos de Oliveira Miguel N; Riemma Pierre MB
J Photochem Photobiol B; 2017 Sep; 174():298-305. PubMed ID: 28818775
[TBL] [Abstract][Full Text] [Related]
12. Future of oncologic photodynamic therapy.
Allison RR; Bagnato VS; Sibata CH
Future Oncol; 2010 Jun; 6(6):929-40. PubMed ID: 20528231
[TBL] [Abstract][Full Text] [Related]
13. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
14. Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrug.
Feuerstein T; Berkovitch-Luria G; Nudelman A; Rephaeli A; Malik Z
Photochem Photobiol Sci; 2011 Dec; 10(12):1926-33. PubMed ID: 22020364
[TBL] [Abstract][Full Text] [Related]
15. Smart activatable and traceable dual-prodrug for image-guided combination photodynamic and chemo-therapy.
Hu F; Yuan Y; Mao D; Wu W; Liu B
Biomaterials; 2017 Nov; 144():53-59. PubMed ID: 28823843
[TBL] [Abstract][Full Text] [Related]
16. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin.
Kloek J; Akkermans W; Beijersbergen van Henegouwen GM
Photochem Photobiol; 1998 Jan; 67(1):150-4. PubMed ID: 9477773
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy combined with photofrin or 5-ALA: effect on Lewis sarcoma tumor lines implanted in mice. Preliminary results.
Schaffer M; Schaffer PM; Jori G; Corti L; Sotti G; Hofstetter A; Dühmke E
Tumori; 2002; 88(5):407-10. PubMed ID: 12487560
[TBL] [Abstract][Full Text] [Related]
18. [5-Aminolevulinic acid esters based photodynamic therapy].
Zhang S; Zhang Z; Jiang D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):310-4. PubMed ID: 12224308
[TBL] [Abstract][Full Text] [Related]
19. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
20. Design and Proof of Programmed 5-Aminolevulinic Acid Prodrug Nanocarriers for Targeted Photodynamic Cancer Therapy.
Wu J; Han H; Jin Q; Li Z; Li H; Ji J
ACS Appl Mater Interfaces; 2017 May; 9(17):14596-14605. PubMed ID: 28397487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]